Director/PDMR Shareholding

24 December 2012

Dechra® Pharmaceuticals PLC

("Dechra" or "the Company")

Director / PDMR shareholding

The Company has been informed that on 21 December 2012, Ed Torr, a director of the Company, sold 50,000 ordinary shares of 1 penny each in the Company ("Ordinary Shares") at an average price of 600.53 pence per share.

Following this transaction, Ed Torr's beneficial interest stands at 424,552 Ordinary Shares, which represents approximately 0.488 per cent. of the Company's issued ordinary share capital.

For further information

Zoe Goulding, Company Secretary

Telephone number: 01782 771100

About Dechra

Dechra is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.